4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-22-048016
Chief Financial Officer bought 20,000 shares at an average $2.55 ($51,020)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2022-08-26 | Purchase | +10,000 | $2.54 | $25,358 | 255,752 | D |
| Byam Rebecca Chief Financial Officer | 2022-08-29 | Purchase | +10,000 | $2.57 | $25,662 | 265,752 | D |
| Open-market purchases · 20,000 sh · avg $2.55 · $51,020 | |||||||
Loading xslF345X03/doc4.xml…